XML 48 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Debt and Other Contractual Obligations - Additional Information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 31, 2017
USD ($)
Jan. 31, 2017
USD ($)
Sep. 30, 2013
USD ($)
Jun. 30, 2017
USD ($)
Facility
Jun. 30, 2016
USD ($)
Jun. 30, 2017
USD ($)
Facility
Loan
Jun. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Debt Instrument [Line Items]                
Owes due to foreign currency revaluation       $ 3,914,000   $ 3,914,000    
Lease agreement term           39 months    
Lease agreement rent free period           3 months    
Capital lease term           60 months    
Deferred revenue       7,191,000   $ 7,191,000   $ 5,624,000
Other income recognized in compliance with covenants       $ 4,650,000   4,650,000    
Proceeds from equipment loans           $ 1,501,000    
Loan for Equipment [Member] | Nottingham, UK Facility [Member]                
Debt Instrument [Line Items]                
Number of loans | Loan           2    
Loan for Equipment [Member] | Loan One [Member] | Nottingham, UK Facility [Member]                
Debt Instrument [Line Items]                
Interest rates at the end of period       2.09%   2.09%    
Proceeds from equipment loans   $ 900,000            
Loan for Equipment [Member] | Loan Two [Member] | Nottingham, UK Facility [Member]                
Debt Instrument [Line Items]                
Interest rates at the end of period       2.09%   2.09%    
Proceeds from equipment loans $ 600,000              
Juniper Pharma Services [Member]                
Debt Instrument [Line Items]                
Debt assumed     $ 3,900,000          
Number of loan facilities | Facility           3    
Number of loan facilities repaid | Facility       1        
Gain loss on refinancing of debt           $ 0    
Owes due to foreign currency revaluation       $ 2,400,000   $ 2,400,000    
Weighted average interest rate for the period       2.76%   2.76%    
Business acquisition maturity period           2017-10    
Juniper Pharma Services [Member] | Regional Growth Fund [Member]                
Debt Instrument [Line Items]                
Debt assumed     $ 2,500,000          
Other income       $ 200,000 $ 200,000 $ 400,000 $ 300,000  
Deferred revenue       200,000   200,000    
Other income recognized in compliance with covenants       $ 200,000   $ 200,000    
Juniper Pharma Services [Member] | Minimum [Member]                
Debt Instrument [Line Items]                
Loan facilities repayment period           7 years    
Juniper Pharma Services [Member] | Maximum [Member]                
Debt Instrument [Line Items]                
Loan facilities repayment period           15 years    
Juniper Pharma Services [Member] | Loan Facility One [Member]                
Debt Instrument [Line Items]                
Loan facilities bear interest rate           1.95%    
Loan facility interest rate description           base rate plus 1.95%    
Interest rates at the end of period       2.45%   2.45%    
Juniper Pharma Services [Member] | Loan Facility Two [Member]                
Debt Instrument [Line Items]                
Loan facilities bear interest rate           2.55%    
Loan facility interest rate description           base rate plus 2.55%    
Interest rates at the end of period       3.05%   3.05%    
Juniper Pharma Services [Member] | Loan Facility Three [Member]                
Debt Instrument [Line Items]                
Loan facilities bear interest rate       2.99%   2.99%